IOL Chemicals and Pharmaceuticals Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹26.07 billion
- Book Value:
- Revenue TTM:
- ₹22.17 billion
- Operating Margin TTM:
- Gross Profit TTM:
- ₹6.96 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
IOL Chemicals and Pharmaceuticals Limited had its IPO on under the ticker symbol IOLCP.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. IOL Chemicals and Pharmaceuticals Limited has a staff strength of 0 employees.
Shares of IOL Chemicals and Pharmaceuticals Limited opened at ₹446.95 at the start of the last trading session i.e. 2023-05-30.
The stocks traded within a range of ₹442 - ₹454.8, and closed at ₹443.1.
This is a -0.37% slip from the previous day's closing price.
A total volume of 269,029 shares were traded at the close of the day’s session.
In the last one week, shares of IOL Chemicals and Pharmaceuticals Limited have increased by +0.44%.
IOL Chemicals and Pharmaceuticals Limited's Key Ratios
IOL Chemicals and Pharmaceuticals Limited has a market cap of ₹26.07 billion, indicating a price to book ratio of 1.3723 and a price to sales ratio of 0.892.
In the last 12-months IOL Chemicals and Pharmaceuticals Limited’s revenue was ₹22.17 billion with a gross profit of ₹6.96 billion and an EBITDA of ₹2.26 billion. The EBITDA ratio measures IOL Chemicals and Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, IOL Chemicals and Pharmaceuticals Limited’s operating margin was 8.1% while its return on assets stood at 5.63% with a return of equity of 9.6%.
In Q1, IOL Chemicals and Pharmaceuticals Limited’s quarterly earnings growth was a positive 117.6% while revenue growth was a positive 2.6%.
IOL Chemicals and Pharmaceuticals Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹23.52 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into IOL Chemicals and Pharmaceuticals Limited’s profitability.
IOL Chemicals and Pharmaceuticals Limited stock is trading at a EV to sales ratio of 0.8913 and a EV to EBITDA ratio of 9.3172. Its price to sales ratio in the trailing 12-months stood at 0.892.
IOL Chemicals and Pharmaceuticals Limited stock pays annual dividends of ₹4 per share, indicating a yield of 0.9% and a payout ratio of 31.57%.
Balance sheet and cash flow metrics
- Total Assets
- ₹20.22 billion
- Total Liabilities
- ₹4.56 billion
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
IOL Chemicals and Pharmaceuticals Limited ended 2023 with ₹20.22 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹20.22 billion while shareholder equity stood at ₹15.08 billion.
IOL Chemicals and Pharmaceuticals Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹4.56 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹13.90 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.
IOL Chemicals and Pharmaceuticals Limited’s total current assets stands at ₹9.20 billion while long-term investments were ₹0 and short-term investments were ₹453.80 million. Its net receivables were ₹5.05 billion compared to accounts payable of ₹3.14 billion and inventory worth ₹3.26 billion.
In 2023, IOL Chemicals and Pharmaceuticals Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, IOL Chemicals and Pharmaceuticals Limited paid ₹0.32 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
IOL Chemicals and Pharmaceuticals Limited stock is currently trading at ₹443.1 per share. It touched a 52-week high of ₹463.45 and a 52-week low of ₹463.45. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹367.64 and 200-day moving average was ₹350.43 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6871.6% of the company’s stock are held by insiders while 205.2% are held by institutions.
Frequently Asked Questions About IOL Chemicals and Pharmaceuticals Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex- ibuprofen; and other APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. Its products are used for treatments, which include anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-cholelithic, as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid for use in food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is headquartered in Ludhiana, India.